Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design
Brandon Malone, Nadya Urakova, Eric J. Snijder, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 21-39
Open Access | Times Cited: 373

Showing 1-25 of 373 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 382
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 94
The mechanism of RNA capping by SARS-CoV-2
Gina J. Park, Adam Osinski, Genaro Hernandez, et al.
Nature (2022)
Open Access | Times Cited: 89
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
SARS-CoV-2 biology and host interactions
Silvio Steiner, Annika Kratzel, G. Tuba Barut, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 4, pp. 206-225
Closed Access | Times Cited: 74
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
Liyan Yang, Zhonglei Wang
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115503-115503
Open Access | Times Cited: 63
Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir “S-217622”: A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species
Wafa Ali Eltayb, Mohnad Abdalla, Amgad M. Rabie
ACS Omega (2023) Vol. 8, Iss. 6, pp. 5234-5246
Open Access | Times Cited: 50
Structural basis for substrate selection by the SARS-CoV-2 replicase
Brandon Malone, Jason K. Perry, Paul Dominic B. Olinares, et al.
Nature (2023) Vol. 614, Iss. 7949, pp. 781-787
Open Access | Times Cited: 46
The Chiral 5,6-Cyclohexane-fused Uracil Ring-System: a Molecular Platform with Promising Activity against SARS-CoV-2
Enrico Marcantonio, Debora Guazzetti, Crescenzo Coppa, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117302-117302
Closed Access | Times Cited: 1
Structural and Mechanistic Insights into the Main Protease (Mpro) Dimer Interface Destabilization Inhibitor: Unveiling New Therapeutic Avenues against SARS-CoV-2
Ankur Singh, Kuldeep Jangid, Sanketkumar Nehul, et al.
Biochemistry (2025)
Closed Access | Times Cited: 1
Giant RNA genomes: Roles of host, translation elongation, genome architecture, and proteome in nidoviruses
Benjamin W. Neuman, Alexandria Smart, Orian Gilmer, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Closed Access | Times Cited: 1
Inhibitors of SARS-CoV-2 PLpro
Dale J. Calleja, Guillaume Lessène, David Komander
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 66
Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2—A narrative review
Sri Masyeni, Muhammad Iqhrammullah, Andri Frediansyah, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3006-3016
Open Access | Times Cited: 62
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
János András Mótyán, Mohamed Mahdi, Gyula Hoffka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3507-3507
Open Access | Times Cited: 61
Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?
Alfredo Parra-Lucares, Paula Segura, Verónica Rojas, et al.
Life (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 42
Development of Metal Complexes for Treatment of Coronaviruses
Hany M. Abd El‐Lateef, Tarek El‐Dabea, Mai M. Khalaf, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6418-6418
Open Access | Times Cited: 39
Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
Lidong Wang, Michelle Møhlenberg, Pengfei Wang, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 70, pp. 13-25
Open Access | Times Cited: 32
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 MPro and PLPro
Hossein Mousavi, Behzad Zeynizadeh, Mehdi Rimaz
Bioorganic Chemistry (2023) Vol. 135, pp. 106390-106390
Open Access | Times Cited: 25
Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase
Mikołaj Żmudziński, Wioletta Rut, Kamila Olech, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9
Nora Schmidt, Sabina Ganskih, Yuanjie Wei, et al.
Cell (2023) Vol. 186, Iss. 22, pp. 4834-4850.e23
Open Access | Times Cited: 25
Deep mining of the Sequence Read Archive reveals major genetic innovations in coronaviruses and other nidoviruses of aquatic vertebrates
Chris Lauber, Xiaoyu Zhang, Josef Vaas, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 4, pp. e1012163-e1012163
Open Access | Times Cited: 12
Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools
Marian Vincenzi, Flavia Anna Mercurio, Marilisa Leone
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1798-1798
Open Access | Times Cited: 11
Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo
Mariska van Huizen, Jonna R. Bloeme - ter Horst, Heidi L.M. De Gruyter, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1012100-e1012100
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top